T. Messele et al., Nonradioactive techniques for measurement of in vitro T-cell proliferation: Alternatives to the [H-3]thymidine incorporation assay, CL DIAG LAB, 7(4), 2000, pp. 687-692
T-cell proliferation is an important in vitro parameter of in vivo immune f
unction and has been used as a prognostic marker of human immunodeficiency
virus type 1 (HIV-1) disease progression. The proliferative capacity of T c
ells in response to various stimuli is commonly determined by a radioactive
assay based on incorporation of [H-3]thymidine ([H-3]TdR) into newly gener
ated DNA. In order to assess techniques for application in laboratories whe
re radioactive facilities are not present, two alternative methods were tes
ted and compared to the [H-3]TdR assay as a "gold standard." As an alternat
ive, T-cell proliferation was measured by flow cytometric assessment of CD3
8 expression on T cells and by an enzyme-linked immunosorbent assay (ELISA)
based on bromo-2'-deoxyuridine (BrdU) incorporation. Peripheral blood mono
nuclear cells (PBMCs), either in whole blood or Ficoll-Isopaque separated,
from a total of 26 HIV-1-positive and 18 HN-l-negative Dutch individuals we
re stimulated with CD3 monoclonal antibody (MAb) alone, a combination of CD
3 and CD28 MAbs, or phytohemagglutinin. BrdU incorporation after 3 days of
stimulation with a combination of CD3 and CD28 MAbs correlated excellently
with the [3H]TdR incorporation in both study groups (HIV-1 positives, r = 0
.96; HIV-1 negatives, r = 0,83). A significant correlation of absolute numb
ers of T cells expressing CD38 with [H-3]TdR incorporation, both in HIV-l-p
ositive (r = 0.96) and HIV-l-negative (1. = 0.84) individuals, was also obs
erved under these conditions. The results of this study indicate that deter
mination of both the number of CD38-positive T cells and BrdU incorporation
can be used as alternative techniques to measure the in vitro T cell proli
ferative capacity, The measurement of CD38 expression on T cells provides t
he additional possibility to further characterize the proliferating T-cell
subsets for expression of other surface markers.